glp 1 meds and pregnancy Study links GLP-1 use to some risks — but the research has key caveats GLP-1 in Pregnancy: Prescribing Trends

Oxid Med Cell Longev 2017:9860841

This puts people at a higher risk for problems, from small side effects to big health issues

Exenatide (Byetta/Bydureon), derived from Gila monster venom, was the first GLP-1 agonist approved in 2005

First characterized in 1977 from rabbit brain tissue extracts

This is the basis of reducing preterm births

Strategies to Minimize Injection Site Reactions Use Proper Injection Technique: Always wash your hands thoroughly Clean the injection site with alcohol and let it dry Use a fresh, sterile syringe every time Inject slowly and gently Rotate injection sites daily (avoid injecting the same spot more than once per week) Pinch the skin to form a small fold when injecting Avoid injecting into irritated, bruised, or scarred tissue Consider Dilution and Buffering: Some peptides (e.g., CJC-1295, BPC-157) may be more acidic depending on the manufacturer